Aerovate Therapeutics
AVTE
#9342
Rank
ยฃ54.21 M
Marketcap
ยฃ1.87
Share price
-0.84%
Change (1 day)
-87.46%
Change (1 year)

Aerovate Therapeutics (AVTE) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : ยฃ8.26 Million

According to Aerovate Therapeutics's latest financial reports the company's total liabilities are ยฃ8.26 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Aerovate Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31ยฃ7.07 M224.23%
2021-12-31ยฃ2.18 M-83.53%
2020-12-31ยฃ13.24 M142.74%
2019-12-31ยฃ5.45 M